
Pharmaceutical Filtration Market Report 2026
Global Outlook – By Product (Membrane Filters, Prefilters And Depth Media, Single-Use Systems, Cartridges And Capsules, Filter Holders, Filtration Accessories, Other Products), By Technique (Microfiltration, Ultrafiltration, Crossflow Filtration, Nanofiltration, Other Techniques), By Scale Of Operation (Manufacturing Scale, Pilot-Scale, Research And Development Scale), By Application (Final Product Processing, Raw Material Filtration, Bioburden Testing, Cell Separation, Water Purification, Air purification) – Market Size, Trends, Strategies, and Forecast to 2035
Pharmaceutical Filtration Market Overview
• Pharmaceutical Filtration market size has reached to $7.65 billion in 2025 • Expected to grow to $10.01 billion in 2030 at a compound annual growth rate (CAGR) of 5.5% • Growth Driver: Rising Demand For Generics Drives The Pharmaceutical Filtration Market • Market Trend: Strategic Partnership To Expand Capabilities • North America was the largest region in 2025.What Is Covered Under Pharmaceutical Filtration Market?
Pharmaceutical filtration is a technique that removes solid particulate matter from a fluid, which can be either liquid or gas, by utilizing a porous medium. It is used in pharmaceutical production sectors to remove pollutants like particulate matter and bacteria from solids, air, liquids, and gases. The main products of the pharmaceutical filtration are membrane filters, prefilters, and depth media, single-use systems, cartridges and capsules, filter holders, and filtration accessories. Membrane filters refer to the flow of fluids or gases while preventing the passage of particles and microorganisms. The various techniques used are microfiltration, ultrafiltration, crossflow filtration, and nanofiltration, which involve scale of operations functions such as manufacturing scale, pilot scale, and research and development scale. The various applications include final product processing, raw material filtration, bioburden testing, cell separation, water purification, and air purification.
What Is The Pharmaceutical Filtration Market Size and Share 2026?
The pharmaceutical filtration market size has grown strongly in recent years. It will grow from $7.65 billion in 2025 to $8.07 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to stringent regulatory compliance, increasing pharmaceutical manufacturing activities, rising demand for sterile products, technological advancements in filtration techniques, expansion of biopharmaceutical production facilities.What Is The Pharmaceutical Filtration Market Growth Forecast?
The pharmaceutical filtration market size is expected to see strong growth in the next few years. It will grow to $10.01 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to growth of biologics and biosimilars, adoption of single-use systems, integration of automation and smart manufacturing, increasing investment in aseptic processing, rising need for contamination-free production. Major trends in the forecast period include advanced filtration membrane development, single-use filtration system adoption, integration of iot in filtration monitoring, automated filtration processes, high-purity water and air filtration demand.Global Pharmaceutical Filtration Market Segmentation
1) By Product: Membrane Filters, Prefilters And Depth Media, Single-Use Systems, Cartridges And Capsules, Filter Holders, Filtration Accessories, Other Products 2) By Technique: Microfiltration, Ultrafiltration, Crossflow Filtration, Nanofiltration, Other Techniques 3) By Scale Of Operation: Manufacturing Scale, Pilot-Scale, Research And Development Scale 4) By Application: Final Product Processing, Raw Material Filtration, Bioburden Testing, Cell Separation, Water Purification, Air purification Subsegments: 1) By Membrane Filters: Microfiltration Filters, Ultrafiltration Filters, Nanofiltration Filters, Reverse Osmosis Filters 2) By Prefilters And Depth Media: Depth Filters, Prefilters for Membrane Systems 3) By Single-Use Systems: Single-Use Filtration Devices, Disposable Filter Assemblies 4) By Cartridges And Capsules: Filter Cartridges, Filter Capsules 5) By Filter Holders: Laboratory Filter Holders, Industrial Filter Holders 6) By Filtration Accessories: Connectors, Housings, Validation Equipment 7) By Other Products: Specialized Filters, Custom Filtration SolutionsWhat Is The Driver Of The Pharmaceutical Filtration Market?
An increase in demand for generic drugs is expected to propel the growth of the pharmaceutical filtration market going forward. Generic pharmaceuticals are medications designed to be the same as an existing approved brand-name drug. Pharmaceutical filtration is used in the process of generic drugs by removing solid particulate matter from a fluid, which can be either liquid or gas, using a porous medium. For instance, in July 2025, according to the U.S. Food and Drug Administration (FDA), a U.S.-based federal government agency, reported that the U.S. healthcare system saved over US$ 400 billion because of the availability of generic medicines. Therefore, the increase in demand for generic drugs is driving the growth of the pharmaceutical filtration industry.Key Players In The Global Pharmaceutical Filtration Market
Major companies operating in the pharmaceutical filtration market are 3M Health Care, Danaher Corporation, Amazon Filters Ltd., Eaton Corporation PLC, GE Healthcare, Graver Technologies LLC, Meissner Filtration Products, Parker Bioscience Filtration, Sartorius AG, Repligen, Porvair PLC, Alfa Laval AB, Corning Incorporated, Thermo Fisher Scientific, Freudenberg Group, Avantor Inc., Berry Global Inc., Cantel Medical Corp., Cole-Parmer Instrument Company LLC, Donaldson Company Inc., Entegris Inc., Filtration Group Corporation, Synder Filtration Inc, GVS S.p.A., Koch Membrane Systems Inc., Lenntech B.V., Mann+Hummel Group, Membrane Solutions, Pall CorporationGlobal Pharmaceutical Filtration Market Trends and Insights
Major companies operating in the pharmaceutical filtration market are adopting a strategic partnership approach aiming to improve downstream purification processes for exosome production. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in January 2023, RoosterBio Inc., a US-based biopharmaceutical company, announced a strategic collaboration with Sartorius AG, a Germany-based pharmaceutical and laboratory equipment company. This partnership aims to provide exceptional expertise and solutions for an exosome manufacturing platform that utilizes human mesenchymal stem/stromal cells (hMSCs). The objective is to achieve industry-leading potency, purity, and yield. The collaboration will primarily focus on developing comprehensive analytical methods for characterizing exosomes and other extracellular vesicles (EVs). This will facilitate the establishment of quantitative quality control strategies for both exosome purification intermediates and the final drug product. Additionally, the partnership will provide scalable filtration equipment, such as Sartoflow Smart and Sartoflow Advanced, to enhance the clarity, concentration, and formulation.What Are Latest Mergers And Acquisitions In The Pharmaceutical Filtration Market?
In May 2023, Xylem Inc., a US-based water technology provider, acquired Evoqua Water Technologies for $7.5 billion. The acquisition positions Xylem to better meet the increasing demands for sustainable water solutions while enhancing its operational capabilities and market presence. Evoqua Water Technologies is a US-based provider of pharmaceutical filtration solutions.Regional Insights
North America was the largest region in the pharmaceutical filtration market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Pharmaceutical Filtration Market?
The pharmaceutical filtration market includes revenues earned by entities by providing reverse osmosis, sterile filtration, chromatography, sterile sampling and nanofiltration. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Pharmaceutical Filtration Market Report 2026?
The pharmaceutical filtration market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical filtration industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Pharmaceutical Filtration Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $8.07 billion |
| Revenue Forecast In 2035 | $10.01 billion |
| Growth Rate | CAGR of 5.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Technique, Scale Of Operation, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | 3M Health Care, Danaher Corporation, Amazon Filters Ltd., Eaton Corporation PLC, GE Healthcare, Graver Technologies LLC, Meissner Filtration Products, Parker Bioscience Filtration, Sartorius AG, Repligen, Porvair PLC, Alfa Laval AB, Corning Incorporated, Thermo Fisher Scientific, Freudenberg Group, Avantor Inc., Berry Global Inc., Cantel Medical Corp., Cole-Parmer Instrument Company LLC, Donaldson Company Inc., Entegris Inc., Filtration Group Corporation, Synder Filtration Inc, GVS S.p.A., Koch Membrane Systems Inc., Lenntech B.V., Mann+Hummel Group, Membrane Solutions, Pall Corporation |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
